Taku Nakashima
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 46
- Lung Cancer Treatments and Mutations 16
- Chronic Obstructive Pulmonary Disease (COPD) Research 14
- Occupational and environmental lung diseases 9
- Neonatal Respiratory Health Research 9
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 11
- Physiology top 10%
- Asthma and respiratory diseases 12
- Genetics top 10%
-
- Advanced Glycation End Products research 9
- Co-authors
- Noboru HattoriHiroshi IwamotoKazunori FujitakaTakeshi MasudaHironobu HamadaYasushi HorimasuShintaro MiyamotoKakuhiro Yamaguchi
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- JapanUnited StatesNorway
In The Last Decade
Taku Nakashima
112 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 118
- Pulmonary and Respiratory Medicine 818
- Oncology 313
- Immunology 178
- Physiology 201
- Genetics 81
Countries citing papers authored by Taku Nakashima
This map shows the geographic impact of Taku Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taku Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taku Nakashima more than expected).
Fields of papers citing papers by Taku Nakashima
This network shows the impact of papers produced by Taku Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taku Nakashima. The network helps show where Taku Nakashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Taku Nakashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 0 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 6 | |
| 17 | 2019 | 12 | |
| 18 | 2018 | 15 | |
| 19 | 2018 | 15 | |
| 20 | 2016 | 54 |
About Taku Nakashima
Taku Nakashima is a scholar working on Pulmonary and Respiratory Medicine, Clinical Biochemistry and Oncology, having authored 125 papers that have together received 1.5k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (46 papers), Lung Cancer Treatments and Mutations (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Asthma and respiratory diseases (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Occupational and environmental lung diseases (9 papers), Neonatal Respiratory Health Research (9 papers) and Advanced Glycation End Products research (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (818 citations), Oncology (313 citations) and Immunology (178 citations). Taku Nakashima has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Noboru Hattori, Hiroshi Iwamoto, Kazunori Fujitaka, Takeshi Masuda, Hironobu Hamada, Yasushi Horimasu, Shintaro Miyamoto, Kakuhiro Yamaguchi, Shinjiro Sakamoto and Nobuoki Kohno. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.